Incyte Corp (INCY)
70.39
-0.66
(-0.93%)
USD |
NASDAQ |
Nov 21, 16:00
70.35
-0.04
(-0.06%)
After-Hours: 20:00
Incyte Profit Margin (Quarterly): 9.36% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 9.36% |
| June 30, 2024 | -42.60% |
| March 31, 2024 | 19.25% |
| December 31, 2023 | 19.84% |
| September 30, 2023 | 18.64% |
| June 30, 2023 | 21.32% |
| March 31, 2023 | 2.68% |
| December 31, 2022 | 3.07% |
| September 30, 2022 | 13.70% |
| June 30, 2022 | 17.71% |
| March 31, 2022 | 5.18% |
| December 31, 2021 | 65.35% |
| September 30, 2021 | 22.35% |
| June 30, 2021 | 21.18% |
| March 31, 2021 | 8.85% |
| December 31, 2020 | 18.98% |
| September 30, 2020 | -2.45% |
| June 30, 2020 | 42.19% |
| March 31, 2020 | -126.8% |
| December 31, 2019 | 19.16% |
| September 30, 2019 | 23.26% |
| June 30, 2019 | 19.87% |
| March 31, 2019 | 20.55% |
| December 31, 2018 | 13.07% |
| September 30, 2018 | 6.49% |
| Date | Value |
|---|---|
| June 30, 2018 | 10.05% |
| March 31, 2018 | -10.76% |
| December 31, 2017 | -33.69% |
| September 30, 2017 | 9.45% |
| June 30, 2017 | -3.82% |
| March 31, 2017 | -48.71% |
| December 31, 2016 | 2.72% |
| September 30, 2016 | 13.69% |
| June 30, 2016 | 13.98% |
| March 31, 2016 | 9.13% |
| December 31, 2015 | 22.62% |
| September 30, 2015 | -21.10% |
| June 30, 2015 | 5.70% |
| March 31, 2015 | -11.53% |
| December 31, 2014 | -29.80% |
| September 30, 2014 | 29.92% |
| June 30, 2014 | -37.03% |
| March 31, 2014 | -37.82% |
| December 31, 2013 | -44.16% |
| September 30, 2013 | -25.89% |
| June 30, 2013 | -2.53% |
| March 31, 2013 | -22.05% |
| December 31, 2012 | 16.50% |
| September 30, 2012 | -35.89% |
| June 30, 2012 | 4.66% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-126.8%
Minimum
Mar 2020
65.35%
Maximum
Dec 2021
7.85%
Average
18.17%
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 25.22% |
| Biomarin Pharmaceutical Inc | 14.22% |
| Syndax Pharmaceuticals Inc | -673.0% |
| Allogene Therapeutics Inc | -- |
| Arcutis Biotherapeutics Inc | -92.81% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 0.75% |
| Return on Assets | 0.54% |
| Return on Invested Capital | 0.75% |
| Gross Profit Margin (Quarterly) | 92.44% |
| Operating Margin (Quarterly) | 14.90% |
| Return on Net Operating Assets | 1.76% |